Greenland Energy Company filed a Form 8-K on October 29, 2026, disclosing that the resignation of board member Roderick McIllree on October 20, 2026, triggered non-compliance notices from Nasdaq related to independent director and audit committee requirements.

Key Highlights

  • Director resignation: Roderick McIllree resigned from the board and all assignments with the company on October 20, 2026.
  • Dual non-compliance: The company notified Nasdaq on October 23, 2026, that it was no longer in compliance with Nasdaq Listing Rule 5605(b)(1) (majority independent directors) and Nasdaq Listing Rule 5605(c)(2)(A) (minimum three independent directors on the audit committee).
  • Cure period granted: Nasdaq's letter dated October 28, 2026, provided a cure period until the earlier of the next annual shareholders' meeting or October 20, 2027, with a condition that compliance must be evidenced no later than April 19, 2027, if the annual meeting is held before that date.
  • Audit committee deficiency cured: On October 27, 2026, the board appointed Melanie Furlan to the audit committee, restoring it to three independent members: Furlan, Scott Wollney, and Carol Craig.
  • Listing status unchanged: According to the filing, the non-compliance "has no immediate effect on the Company's Nasdaq listing" and shares continue to trade under NASDAQ:GLND and warrants under GLNDW.

Greenland Energy's Board Compliance Status Following the McIllree Resignation

According to the filing, Roderick McIllree's departure from the board on October 20, 2026, left Greenland Energy Company out of compliance with two Nasdaq governance rules. The company disclosed on October 23, 2026, that it no longer met the majority independent director standard under Nasdaq Listing Rule 5605(b)(1), and that its audit committee fell below the three-independent-director minimum required by Nasdaq Listing Rule 5605(c)(2)(A).

Nasdaq responded with a letter dated October 28, 2026, granting the company a cure period. The company reported that the deadline for regaining compliance is the earlier of its next annual shareholders' meeting or October 20, 2027. The filing specifies, however, that if the next annual meeting is held before April 19, 2027, the company must demonstrate compliance no later than April 19, 2027. The company disclosed that it "intends to take sufficient actions to regain compliance with all of the foregoing Nasdaq governance requirements on or before the expiration of the applicable cure periods."

The filing also noted that the audit committee deficiency was addressed before the 8-K was filed. On October 27, 2026, the board appointed Melanie Furlan, described as a current independent director, to the audit committee. With her addition, the committee is comprised of three independent members: Furlan, Scott Wollney, and Carol Craig. The majority independent director requirement, however, remains unresolved as of the filing date, and the company is working within the Nasdaq-provided cure window to address it. The filing contains forward-looking statements, which the company notes are subject to risks and uncertainties described in its other regulatory filings.

What Was Disclosed

Greenland Energy Company disclosed in this 8-K that a board member's resignation created two Nasdaq listing rule deficiencies. One deficiency, involving the audit committee's size, was cured on October 27, 2026. The majority independent director deficiency remains subject to a Nasdaq-granted cure period ending no later than October 20, 2027.